Omnipod Insulin Management System Recall in Canada
Identify affected lots and implement recall procedures as per Health Canada guidelines.
2 SOPs may need review
Tag archive
Identify affected lots and implement recall procedures as per Health Canada guidelines.
2 SOPs may need review
1) Retrieve and review the updated “Submitting risk management plans guidance document” (PDF) and linked templates referenced from the overview (e.g., RMP note to reviewer, Canadian-specific addendum, RMP summary template) and map deltas vs the superseded 2015 approach. 2) Update Canada submission checklists/work instructions for the 1 July 2025 effective date, including the requirement that the RMP include a summary in English and French and use of the RMP summary attestation/acknowledgment form. 3) Ask Regulatory Intelligence/RA to brief PV leadership on the Agile Licensing notice timeline (RMP provisions in force 1 April 2027) and confirm how transitional provisions will be operationalized for existing RMPs submitted prior to that date.
5 SOPs may need review
Health Canada update requires triage for Local Affiliate Compliance, Inspection Readiness, Risk Management; confirm local obligations and document follow-up actions.
5 SOPs may need review
Health Canada update requires triage for Local Affiliate Compliance, Device Vigilance, Inspection Readiness; confirm local obligations and document follow-up actions.
4 SOPs may need review
Subscribe to receive impact-first pharmacovigilance updates tailored by role and workflow.
Current context: role All, workflow All.